chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 61.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Rash
Clinical narrative: Hot to the touch; Itch; Body aches; rashes on hands and face; Fever; Joint pain; Fatigue; This spontaneous case was reported by a consumer and describes the occurrence of FEELING HOT (Hot to the touch), PRURITUS (Itch), PAIN (Body aches), RASH (rashes on hands and face) and PYREXIA (Fever) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Fibromyalgia. Concomitant products included MILNACIPRAN HYDROCHLORIDE (SAVELLA), DICLOFENAC POTASSIUM (VOLTAREN ACTI) and TRAZODONE for Fibromyalgia.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 16-Mar-2021, the patient experienced FEELING HOT (Hot to the touch), PRURITUS (Itch), PAIN (Body aches), RASH (rashes on hands and face), PYREXIA (Fever), ARTHRALGIA (Joint pain) and FATIGUE (Fatigue). At the time of the report, FEELING HOT (Hot to the touch), PRURITUS (Itch), PAIN (Body aches), RASH (rashes on hands and face), PYREXIA (Fever), ARTHRALGIA (Joint pain) and FATIGUE (Fatigue) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No treatment details pertained to the events were provided.
Age: 71.0
Sex: M
Vaccine: COVID19
Symptoms: Bite, Paraesthesia
Clinical narrative: Right palm felt a sensation (like a pinprick)/Left palm felt a sensation (like a pinprick); Bit lip 3 times in a row; This spontaneous case was reported by a consumer and describes the occurrence of PARAESTHESIA (Right palm felt a sensation (like a pinprick)/Left palm felt a sensation (like a pinprick)) and BITE (Bit lip 3 times in a row) in a 71-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 001A21A and 029L20A) for COVID-19 vaccination.     The patient's past medical history included Rhabdomyolysis. Concomitant products included ACETYLSALICYLIC ACID (BABY ASPIRIN), METOPROLOL and ROSUVASTATIN for an unknown indication.   On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 22-Feb-2021, the patient experienced PARAESTHESIA (Right palm felt a sensation (like a pinprick)/Left palm felt a sensation (like a pinprick)) and BITE (Bit lip 3 times in a row). At the time of the report, PARAESTHESIA (Right palm felt a sensation (like a pinprick)/Left palm felt a sensation (like a pinprick)) and BITE (Bit lip 3 times in a row) outcome was unknown.            Patient reported Allergy to one of the statins and on 23Feb2021 Bit lip another 3-4 times in a row. No Treatments were reported.   This case was linked to MOD-2021-054797 (Patient Link).
Sex: F
Vaccine: COVID19
Symptoms: Chills, Myalgia, Nausea, Pain in extremity, Pyrexia
Clinical narrative: This spontaneous case was reported by a patient and describes the occurrence of PAIN IN EXTREMITY (Sore arm), MYALGIA (achy), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 014M20A) for COVID-19 vaccination. Concurrent medical conditions included Thalassemia minor and Mitral valve disease NOS (mitral valve problem).  On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (Sore arm), MYALGIA (achy), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea). At the time of the report, PAIN IN EXTREMITY (Sore arm), MYALGIA (achy), PYREXIA (Fever), CHILLS (Chills) and NAUSEA (Nausea) outcome was unknown. Concomitant medication and treatment information were not reported. Due to existing medical history the patient does not want to take the second dose. Action taken with mRNA-1273 in response to the event was Not Applicable.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site erythema, Vaccination site pain, Vaccination site pruritus, Vaccination site swelling
Clinical narrative: Itching at the site of the injection in left arm; Swelling at the site of the injection in left arm; Redness at the site of the injection in left arm; Pain at the site of the injection in left arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PRURITUS (Itching at the site of the injection in left arm), VACCINATION SITE SWELLING (Swelling at the site of the injection in left arm), VACCINATION SITE ERYTHEMA (Redness at the site of the injection in left arm) and VACCINATION SITE PAIN (Pain at the site of the injection in left arm) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Psoriatic arthritis. Concomitant products included ADALIMUMAB (HUMIRA) for Psoriatic arthritis.    On 15-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Itching at the site of the injection in left arm), VACCINATION SITE SWELLING (Swelling at the site of the injection in left arm), VACCINATION SITE ERYTHEMA (Redness at the site of the injection in left arm) and VACCINATION SITE PAIN (Pain at the site of the injection in left arm). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, VACCINATION SITE PRURITUS (Itching at the site of the injection in left arm) was resolving and VACCINATION SITE SWELLING (Swelling at the site of the injection in left arm), VACCINATION SITE ERYTHEMA (Redness at the site of the injection in left arm) and VACCINATION SITE PAIN (Pain at the site of the injection in left arm) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment included  ice packs.
Age: 14.0
Sex: M
Vaccine: COVID19
Symptoms: Epistaxis, Photophobia, Product administered to patient of inappropriate age
Clinical narrative: Bleeding nose; Light sensitivity to eye; Special Population : Younger than 18 years old; This spontaneous case was reported by a consumer and describes the occurrence of PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Special Population : Younger than 18 years old), EPISTAXIS (Bleeding nose) and PHOTOPHOBIA (Light sensitivity to eye) in a 14-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 20-Mar-2021, the patient experienced PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Special Population : Younger than 18 years old). On 22-Mar-2021, the patient experienced EPISTAXIS (Bleeding nose) and PHOTOPHOBIA (Light sensitivity to eye). On 20-Mar-2021, PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE (Special Population : Younger than 18 years old) had resolved. At the time of the report, EPISTAXIS (Bleeding nose) and PHOTOPHOBIA (Light sensitivity to eye) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter.  Treatment information was not provided.  Company comment: This report refers to a case of product administered to patient of inappropriate age (14 year old male) for mRNA-1273 (lot number 007B21A) with associated AEs reported as sensitivity to light and bleeding nose two days after vaccination and causal relationship cannot be excluded.   Most recent FOLLOW-UP information incorporated above includes: On 03-Jun-2021: Added reporter name and Email ID. Updated outcome of the events as recovered. On 03-Jun-2021: Contains no new information.; Sender's Comments: This report refers to a case of product administered to patient of inappropriate age (14 year old male) for mRNA-1273 (lot number 007B21A) with associated AEs reported as sensitivity to light and bleeding nose two days after vaccination and causal relationship cannot be excluded.
Sex: F
Vaccine: COVID19
Symptoms: Dizziness
Clinical narrative: This spontaneous case was reported by a consumer and describes the occurrence of DIZZINESS (Feeling woozy) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.   On 22-Mar-2021 at 9:00 AM, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 22-Mar-2021, the patient experienced DIZZINESS (Feeling woozy). At the time of the report, DIZZINESS (Feeling woozy) had not resolved.            Treatment details was not provided. Concomitant medications included unspecified medications for blood pressure  Action taken with mRNA-1273 in response to the event was Not Applicable   This case was linked to US-MODERNATX, INC.-MOD-2021-054884 (E2B Linked Report).   Reporter did not allow further contact; Sender's Comments:  US-MODERNATX, INC.-MOD-2021-054884:Same reporter link
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Diarrhoea, Dry skin, Erythema, Pain in extremity, Paraesthesia
Clinical narrative: Diarrhea; Dry Skin; Arm Pain; Redness; Itchy Sensation - All Over Body; Restlessness; Tingling Sensation - All Over Body; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), DRY SKIN (Dry Skin), PAIN IN EXTREMITY (Arm Pain), ERYTHEMA (Redness) and PRURITUS (Itchy Sensation - All Over Body) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Osteoarthritis, Inflammatory bowel disease, Osteopenia and Carpal tunnel syndrome. Concomitant products included PARACETAMOL (TYLENOL) for Osteoarthritis, Inflammatory bowel disease, Osteopenia and Carpal tunnel syndrome.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced DIARRHOEA (Diarrhea), DRY SKIN (Dry Skin), PAIN IN EXTREMITY (Arm Pain), ERYTHEMA (Redness), PRURITUS (Itchy Sensation - All Over Body), RESTLESSNESS (Restlessness) and PARAESTHESIA (Tingling Sensation - All Over Body). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at a dose of UNK dosage form. At the time of the report, DIARRHOEA (Diarrhea), DRY SKIN (Dry Skin), PAIN IN EXTREMITY (Arm Pain), ERYTHEMA (Redness), PRURITUS (Itchy Sensation - All Over Body), RESTLESSNESS (Restlessness) and PARAESTHESIA (Tingling Sensation - All Over Body) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medication included blood pressure medication. Treatment included "Tylenol", "calming lotion" and "body wash" to alleviate the symptoms.
Age: 52.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Restlessness
Clinical narrative: Diarrhea; Dry Skin; Arm Pain; Redness; Itchy Sensation - All Over Body; Restlessness; Tingling Sensation - All Over Body; This spontaneous case was reported by a consumer and describes the occurrence of DIARRHOEA (Diarrhea), DRY SKIN (Dry Skin), PAIN IN EXTREMITY (Arm Pain), ERYTHEMA (Redness) and PRURITUS (Itchy Sensation - All Over Body) in a 52-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030L20A) for an unknown indication. The occurrence of additional non-serious events is detailed below.     Concurrent medical conditions included Osteoarthritis, Inflammatory bowel disease, Osteopenia and Carpal tunnel syndrome. Concomitant products included PARACETAMOL (TYLENOL) for Osteoarthritis, Inflammatory bowel disease, Osteopenia and Carpal tunnel syndrome.    On 25-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced DIARRHOEA (Diarrhea), DRY SKIN (Dry Skin), PAIN IN EXTREMITY (Arm Pain), ERYTHEMA (Redness), PRURITUS (Itchy Sensation - All Over Body), RESTLESSNESS (Restlessness) and PARAESTHESIA (Tingling Sensation - All Over Body). The patient was treated with IBUPROFEN (ADVIL [IBUPROFEN]) for Adverse event, at a dose of UNK dosage form. At the time of the report, DIARRHOEA (Diarrhea), DRY SKIN (Dry Skin), PAIN IN EXTREMITY (Arm Pain), ERYTHEMA (Redness), PRURITUS (Itchy Sensation - All Over Body), RESTLESSNESS (Restlessness) and PARAESTHESIA (Tingling Sensation - All Over Body) outcome was unknown.        mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosing remained unchanged.       Concomitant medication included blood pressure medication. Treatment included "Tylenol", "calming lotion" and "body wash" to alleviate the symptoms.
Sex: F
Vaccine: COVID19, UNK
Symptoms: Dry eye, Dry mouth, Sinus disorder, Skin exfoliation
Clinical narrative: SINUS ISSUES; DRY EYES; DRY MOUTH; PEELING SKIN; This spontaneous case was reported by a consumer and describes the occurrence of SINUS DISORDER (SINUS ISSUES), DRY EYE (DRY EYES), DRY MOUTH (DRY MOUTH) and SKIN EXFOLIATION (PEELING SKIN) in an adult female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.    Co-suspect product included non-company product TUCATINIB (TUKYSA) for Breast neoplasm malignant female.    Concurrent medical conditions included Breast neoplasm malignant female. Concomitant products included APIXABAN (ELIQUIS), BISOPROLOL FUMARATE, EXEMESTANE, ACYCLOVIR [ACICLOVIR], DILTIAZEM HYDROCHLORIDE (DILTIAZEM HCL EXTE-REL), LORAZEPAM (ATIVAN), PROCHLORPERAZINE MALEATE and LACTOBACILLUS NOS (CULTURELLE) for an unknown indication.   On an unknown date, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage form and TUCATINIB (TUKYSA) (unknown route) dosage form. On an unknown date, the patient experienced SINUS DISORDER (SINUS ISSUES), DRY EYE (DRY EYES), DRY MOUTH (DRY MOUTH) and SKIN EXFOLIATION (PEELING SKIN). At the time of the report, SINUS DISORDER (SINUS ISSUES), DRY EYE (DRY EYES), DRY MOUTH (DRY MOUTH) and SKIN EXFOLIATION (PEELING SKIN) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No Treatment medications were reported.
Age: 82.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Hyperhidrosis, Nausea
Clinical narrative: sweating profusely; very dizzy; nauseas; This spontaneous case was reported by a consumer and describes the occurrence of HYPERHIDROSIS (sweating profusely), DIZZINESS (very dizzy) and NAUSEA (nauseas) in an 82-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 048A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 23-Mar-2021, the patient experienced HYPERHIDROSIS (sweating profusely), DIZZINESS (very dizzy) and NAUSEA (nauseas). At the time of the report, HYPERHIDROSIS (sweating profusely), DIZZINESS (very dizzy) and NAUSEA (nauseas) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.   Most recent FOLLOW-UP information incorporated above includes: On 10-May-2021: Follow-up information received on 10-MAY-2021.Added AEs has resolved and declined further Follow up as consumer stated.
Age: 75.0
Sex: M
Vaccine: COVID19
Symptoms: Asthenia, Chills, Feeling abnormal, Pyrexia
Clinical narrative: feeling funny; weak; temperature fluctuating between 100.4F; shivering; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (feeling funny), ASTHENIA (weak), PYREXIA (temperature fluctuating between 100.4F) and CHILLS (shivering) in a 75-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 038A21A) for COVID-19 vaccination.     No medical history was provided by the reporter.  Concomitant products included MELOXICAM, FINASTERIDE, TAMSULOSIN, LEFLUNOMIDE and OMEPRAZOLE for an unknown indication, DULOXETINE.    On 22-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 23-Mar-2021, the patient experienced FEELING ABNORMAL (feeling funny), ASTHENIA (weak), PYREXIA (temperature fluctuating between 100.4F) and CHILLS (shivering). The patient was treated with PARACETAMOL (TYLENOL) for Adverse event, at an unspecified dose and frequency. At the time of the report, FEELING ABNORMAL (feeling funny), ASTHENIA (weak), PYREXIA (temperature fluctuating between 100.4F) and CHILLS (shivering) outcome was unknown.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Anxiety, Chills, Dehydration, Headache, Myalgia
Clinical narrative: Some anxiety; Little dehydrated; a little nausea; Chills; Headache; Body pain; This spontaneous case was reported by a patient and describes the occurrence of ANXIETY (Some anxiety), DEHYDRATION (Little dehydrated), NAUSEA (a little nausea), CHILLS (Chills) and HEADACHE (Headache) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Motor vehicle accident. Concurrent medical conditions included Allergy and Pain. Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Allergy.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced ANXIETY (Some anxiety), DEHYDRATION (Little dehydrated), NAUSEA (a little nausea), CHILLS (Chills), HEADACHE (Headache) and MYALGIA (Body pain). On 21-Mar-2021, CHILLS (Chills) outcome was unknown. At the time of the report, ANXIETY (Some anxiety), DEHYDRATION (Little dehydrated), NAUSEA (a little nausea), HEADACHE (Headache) and MYALGIA (Body pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient asked whether the vaccine exacerbated the pain she already experiences. No treatment information was reported
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: Some anxiety; Little dehydrated; a little nausea; Chills; Headache; Body pain; This spontaneous case was reported by a patient and describes the occurrence of ANXIETY (Some anxiety), DEHYDRATION (Little dehydrated), NAUSEA (a little nausea), CHILLS (Chills) and HEADACHE (Headache) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included Motor vehicle accident. Concurrent medical conditions included Allergy and Pain. Concomitant products included DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) for Allergy.    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 19-Mar-2021, the patient experienced ANXIETY (Some anxiety), DEHYDRATION (Little dehydrated), NAUSEA (a little nausea), CHILLS (Chills), HEADACHE (Headache) and MYALGIA (Body pain). On 21-Mar-2021, CHILLS (Chills) outcome was unknown. At the time of the report, ANXIETY (Some anxiety), DEHYDRATION (Little dehydrated), NAUSEA (a little nausea), HEADACHE (Headache) and MYALGIA (Body pain) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient asked whether the vaccine exacerbated the pain she already experiences. No treatment information was reported
Age: 73.0
Sex: M
Vaccine: COVID19
Symptoms: Dyspnoea
Clinical narrative: extreme shortness of breath/could not roll over in bed without being out breath/walk 5 ft without being out of breath; This spontaneous case was reported by a consumer and describes the occurrence of DYSPNOEA (extreme shortness of breath/could not roll over in bed without being out breath/walk 5 ft without being out of breath) in a 73-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 001B21A) for COVID-19 vaccination.     Concomitant products included PREDNISONE and ALENDRONIC ACID for an unknown indication.   On an unknown date, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On an unknown date, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On an unknown date, the patient experienced DYSPNOEA (extreme shortness of breath/could not roll over in bed without being out breath/walk 5 ft without being out of breath). At the time of the report, DYSPNOEA (extreme shortness of breath/could not roll over in bed without being out breath/walk 5 ft without being out of breath) had not resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medications were not provided.  Treatment information was not provided.  Reporter description of events:  Approximately 36 hours to 48 hours after 2nd Moderna Covid-19 vaccine, caller started getting shortness of breath. The shortness of breath got increasingly worse until 6 days after vaccine. On the 6th day he thought he was going to die, he could not roll over in bed without being out breath or walk 5 ft without being out of breath. On the 7th day post vaccine he felt a little better. Today is the 8th day and he feels the same as the 7th day.
Age: 74.0
Sex: M
Vaccine: COVID19
Symptoms: Bone pain, Chills, Myalgia, Pain, Paraesthesia
Clinical narrative: legs tickly from knee down; pain in bones and muscles; Every bone in body is hurting; chilling; pain in bones and muscles; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PARAESTHESIA (legs tickly from knee down), BONE PAIN (pain in bones and muscles), PAIN (Every bone in body is hurting), CHILLS (chilling) and MYALGIA (pain in bones and muscles) in a 74-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 047A21A) for COVID-19 vaccination.     Concurrent medical conditions included Chronic disease (unspecified).    On 19-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 19-Mar-2021, the patient experienced PARAESTHESIA (legs tickly from knee down), BONE PAIN (pain in bones and muscles), PAIN (Every bone in body is hurting), CHILLS (chilling) and MYALGIA (pain in bones and muscles). At the time of the report, PARAESTHESIA (legs tickly from knee down), BONE PAIN (pain in bones and muscles), PAIN (Every bone in body is hurting), CHILLS (chilling) and MYALGIA (pain in bones and muscles) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported.   No treatment medications provided by the reporter.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Product dose omission issue
Clinical narrative: This spontaneous case reported by a consumer, describes the occurrence of product dose omission issue (only received first injection) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 vaccine, batch# 041L20A) for COVID-19 immunization. No medical history reported. On Feb 7, 2021, patient received first dose of mRNA-1273 (Moderna COVID-19 vaccine), unknown route; 1 dosage form. On Feb 7, 2021, patient experienced product dose omission issue (only received first injection). On Feb 7, 2021, product dose omission issue (only received first injection) resolved. The action taken with mRNA-1273 (Moderna COVID-19 vaccine): unknown. Concomitant medication and treatment information not reported. Reporter did not allow further contact.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Body temperature, Pain in extremity, Pruritus, Pyrexia, Vaccination site erythema
Clinical narrative: This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Pain in arm), PRURITUS (Itching), VACCINATION SITE PRURITUS (Vaccination site pruritus), VACCINATION SITE RASH (Vaccination site rash) and VACCINATION SITE ERYTHEMA (Vaccination site erythema) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 17-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm). On 18-Mar-2021, the patient experienced PRURITUS (Itching), VACCINATION SITE RASH (Vaccination site rash) and PYREXIA (fever ). On 22-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Vaccination site pruritus) and VACCINATION SITE ERYTHEMA (Vaccination site erythema). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (topical) for Itchy, at a dose of 1 dosage form; CORTISONE (topical) for Itchy, at a dose of 1 dosage form and HAMAMELIS VIRGINIANA EXTRACT (WITCH HAZEL [HAMAMELIS VIRGINIANA EXTRACT]) (topical) ongoing since an unknown date for Itchy, at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Pain in arm), PRURITUS (Itching), VACCINATION SITE PRURITUS (Vaccination site pruritus), VACCINATION SITE RASH (Vaccination site rash), VACCINATION SITE ERYTHEMA (Vaccination site erythema) and PYREXIA (fever ) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Mar-2021, Body temperature: 101 (Inconclusive) 101°F. No relevant concomitant medications were reported. Action taken for Moderna COVID-19 Vaccine was not applicable. Most recent FOLLOW-UP information incorporated above includes: On 22-Mar-2021: No new information was provided.
Age: 77.0
Sex: F
Vaccine: COVID19
Symptoms: Vaccination site pruritus, Vaccination site rash
Clinical narrative: This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Pain in arm), PRURITUS (Itching), VACCINATION SITE PRURITUS (Vaccination site pruritus), VACCINATION SITE RASH (Vaccination site rash) and VACCINATION SITE ERYTHEMA (Vaccination site erythema) in a 77-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below. No Medical History information was reported. On 17-Mar-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 17-Mar-2021, the patient experienced PAIN IN EXTREMITY (Pain in arm). On 18-Mar-2021, the patient experienced PRURITUS (Itching), VACCINATION SITE RASH (Vaccination site rash) and PYREXIA (fever ). On 22-Mar-2021, the patient experienced VACCINATION SITE PRURITUS (Vaccination site pruritus) and VACCINATION SITE ERYTHEMA (Vaccination site erythema). The patient was treated with DIPHENHYDRAMINE HYDROCHLORIDE (BENADRYL [DIPHENHYDRAMINE HYDROCHLORIDE]) (topical) for Itchy, at a dose of 1 dosage form; CORTISONE (topical) for Itchy, at a dose of 1 dosage form and HAMAMELIS VIRGINIANA EXTRACT (WITCH HAZEL [HAMAMELIS VIRGINIANA EXTRACT]) (topical) ongoing since an unknown date for Itchy, at a dose of 1 dosage form. At the time of the report, PAIN IN EXTREMITY (Pain in arm), PRURITUS (Itching), VACCINATION SITE PRURITUS (Vaccination site pruritus), VACCINATION SITE RASH (Vaccination site rash), VACCINATION SITE ERYTHEMA (Vaccination site erythema) and PYREXIA (fever ) outcome was unknown. DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 18-Mar-2021, Body temperature: 101 (Inconclusive) 101°F. No relevant concomitant medications were reported. Action taken for Moderna COVID-19 Vaccine was not applicable. Most recent FOLLOW-UP information incorporated above includes: On 22-Mar-2021: No new information was provided.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain, Pain in extremity
Clinical narrative: Sore arm; Tender at injection site; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (Sore arm) and INJECTION SITE PAIN (Tender at injection site) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 011A21A and 042L20A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 24-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 24-Feb-2021, the patient experienced PAIN IN EXTREMITY (Sore arm) and INJECTION SITE PAIN (Tender at injection site). The patient was treated with PARACETAMOL (TYLENOL) at a dose of UNK dosage form. At the time of the report, PAIN IN EXTREMITY (Sore arm) and INJECTION SITE PAIN (Tender at injection site) outcome was unknown. Not Provided          No concomitant medications were reported.    Action taken with mRNA-1273 in response to the events was not Applicable.   This case was linked to MOD-2021-054651 (Patient Link).
Age: 83.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Headache, Pain in extremity
Clinical narrative: pain in her arm; bit dizzy at the time of getting vaccinated; pounding headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (pain in her arm), DIZZINESS (bit dizzy at the time of getting vaccinated) and HEADACHE (pounding headache) in an 83-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007B21A) for COVID-19 vaccination.     No Medical History information was reported.    On 22-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in her arm), DIZZINESS (bit dizzy at the time of getting vaccinated) and HEADACHE (pounding headache). At the time of the report, PAIN IN EXTREMITY (pain in her arm), DIZZINESS (bit dizzy at the time of getting vaccinated) and HEADACHE (pounding headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       No concomitant medications were reported. Treatment medication was not provided by the reporter.
Age: 69.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pain
Clinical narrative: nausea; Headache; feeling ache; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nausea), HEADACHE (Headache) and PAIN (feeling ache) in a 69-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006M20A and 038A20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included LEVOTHYROXINE SODIUM (SYNTHYROID) for an unknown indication.   On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Mar-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Mar-2021, the patient experienced NAUSEA (nausea), HEADACHE (Headache) and PAIN (feeling ache). At the time of the report, NAUSEA (nausea), HEADACHE (Headache) and PAIN (feeling ache) had not resolved. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was reported. Action taken with mRNA-1273 in response to the event was not applicable.
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Antibody test, Asthenia, Blood pressure increased, Dyspnoea, Nausea
Clinical narrative: Severe weakness; shortness of breath; Blood pressure increased; a little fever; severe nausea; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Severe weakness), DYSPNOEA (shortness of breath), BLOOD PRESSURE INCREASED (Blood pressure increased), PYREXIA (a little fever) and NAUSEA (severe nausea) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure management and Asthma. Concomitant products included TIOTROPIUM BROMIDE MONOHYDRATE (SPIRIVA RESPIMAT) for Asthma, CENTRUM VITAMINTS for an unknown indication.    On 15-Mar-2021 at 3:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced ASTHENIA (Severe weakness), DYSPNOEA (shortness of breath), BLOOD PRESSURE INCREASED (Blood pressure increased), PYREXIA (a little fever) and NAUSEA (severe nausea). On 25-Apr-2021, ASTHENIA (Severe weakness) had not resolved and DYSPNOEA (shortness of breath), BLOOD PRESSURE INCREASED (Blood pressure increased), PYREXIA (a little fever) and NAUSEA (severe nausea) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Feb-2021, SARS-CoV-2 test: (Positive) Patient was tested positive for COVID-19.. On 14-Apr-2021, Antibody test: (High) Patient's antibody test showed increase in antibodies..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Other concomitant medication provided by the patient was blood pressure medication. No treatment medications were reported   This case was linked to MOD-2021-054697 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Patient demographics added, Lab data added, medical history and concomitant medications added, new events added, outcome of event(pyrexia) changed from unknown to recovered
Age: 60.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia, SARS-CoV-2 test
Clinical narrative: Severe weakness; shortness of breath; Blood pressure increased; a little fever; severe nausea; This spontaneous case was reported by a consumer and describes the occurrence of ASTHENIA (Severe weakness), DYSPNOEA (shortness of breath), BLOOD PRESSURE INCREASED (Blood pressure increased), PYREXIA (a little fever) and NAUSEA (severe nausea) in a 60-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 044A21A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure management and Asthma. Concomitant products included TIOTROPIUM BROMIDE MONOHYDRATE (SPIRIVA RESPIMAT) for Asthma, CENTRUM VITAMINTS for an unknown indication.    On 15-Mar-2021 at 3:30 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Mar-2021, the patient experienced ASTHENIA (Severe weakness), DYSPNOEA (shortness of breath), BLOOD PRESSURE INCREASED (Blood pressure increased), PYREXIA (a little fever) and NAUSEA (severe nausea). On 25-Apr-2021, ASTHENIA (Severe weakness) had not resolved and DYSPNOEA (shortness of breath), BLOOD PRESSURE INCREASED (Blood pressure increased), PYREXIA (a little fever) and NAUSEA (severe nausea) had resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 07-Feb-2021, SARS-CoV-2 test: (Positive) Patient was tested positive for COVID-19.. On 14-Apr-2021, Antibody test: (High) Patient's antibody test showed increase in antibodies..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Other concomitant medication provided by the patient was blood pressure medication. No treatment medications were reported   This case was linked to MOD-2021-054697 (Patient Link).   Most recent FOLLOW-UP information incorporated above includes: On 25-May-2021: Patient demographics added, Lab data added, medical history and concomitant medications added, new events added, outcome of event(pyrexia) changed from unknown to recovered
Age: 71.0
Sex: F
Vaccine: COVID19
Symptoms: Limb discomfort, Pain in extremity, Vaccination site inflammation, Vaccination site rash
Clinical narrative: Inflamed injection site; Rash at injection site; Unable to lay on injection arm; Really sore arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE INFLAMMATION (Inflamed injection site), LIMB DISCOMFORT (Unable to lay on injection arm), PAIN IN EXTREMITY (Really sore arm) and VACCINATION SITE RASH (Rash at injection site) in a 71-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 12-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Mar-2021, the patient experienced LIMB DISCOMFORT (Unable to lay on injection arm) and PAIN IN EXTREMITY (Really sore arm). On 20-Mar-2021, the patient experienced VACCINATION SITE INFLAMMATION (Inflamed injection site) and VACCINATION SITE RASH (Rash at injection site). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, VACCINATION SITE INFLAMMATION (Inflamed injection site), LIMB DISCOMFORT (Unable to lay on injection arm), PAIN IN EXTREMITY (Really sore arm) and VACCINATION SITE RASH (Rash at injection site) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medications were not reported.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash, Urticaria
Clinical narrative: rashes at inner thighs up to the neck; hives at inner thighs up to the neck; patient reported major itching symptoms; This spontaneous case was reported by a patient (subsequently medically confirmed) and describes the occurrence of RASH (rashes at inner thighs up to the neck), URTICARIA (hives at inner thighs up to the neck) and PRURITUS (patient reported major itching symptoms) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 20-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 25-Feb-2021, the patient experienced RASH (rashes at inner thighs up to the neck), URTICARIA (hives at inner thighs up to the neck) and PRURITUS (patient reported major itching symptoms). At the time of the report, RASH (rashes at inner thighs up to the neck), URTICARIA (hives at inner thighs up to the neck) and PRURITUS (patient reported major itching symptoms) was resolving. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       Treatment: Antihistamine medications as a corrective treatment.  Patient developed rashes and hives at inner thighs up to the neck, 5 days after the 1st shot. The patient felt better now. According to patient the rash was persisting for more than 3 and a half weeks
Age: 81.0
Sex: F
Vaccine: COVID19
Symptoms: Myalgia, Nausea
Clinical narrative: Severe muscle pain all over the body; Nausea; This spontaneous case was reported by a consumer and describes the occurrence of MYALGIA (Severe muscle pain all over the body) and NAUSEA (Nausea) in an 81-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 13A21A) for COVID-19 vaccination.     No Medical History information was reported.    On 26-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced MYALGIA (Severe muscle pain all over the body). 27-Feb-2021, the patient experienced NAUSEA (Nausea). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency and ONDANSETRON at an unspecified dose and frequency. At the time of the report, MYALGIA (Severe muscle pain all over the body) and NAUSEA (Nausea) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant medication list was not provided. The patient reported that she felt better after three days.   Most recent FOLLOW-UP information incorporated above includes: On 15-Jun-2021: Follow-up received on 15-Jun-2021 and does not contain any new information.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal pain, Anxiety, Blood thyroid stimulating hormone, Body temperature, Dysmenorrhoea
Clinical narrative: Hyperthyroid symptoms; Intense pain in feet; racing heartbeat; Intense pain in abdomen; Intense brain fog; Anxious; felt like she was having a period; lymph nodes are swollen and inflamed; Fever of 101.6 degrees; nausea; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of THYROID DISORDER (Hyperthyroid symptoms), PAIN IN EXTREMITY (Intense pain in feet), PALPITATIONS (racing heartbeat), ABDOMINAL PAIN (Intense pain in abdomen) and FEELING ABNORMAL (Intense brain fog) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced THYROID DISORDER (Hyperthyroid symptoms), PAIN IN EXTREMITY (Intense pain in feet), PALPITATIONS (racing heartbeat), ABDOMINAL PAIN (Intense pain in abdomen), FEELING ABNORMAL (Intense brain fog), ANXIETY (Anxious), DYSMENORRHOEA (felt like she was having a period), LYMPHADENOPATHY (lymph nodes are swollen and inflamed), PYREXIA (Fever of 101.6 degrees) and NAUSEA (nausea). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Adverse event, at a dose of UNK dosage form and FAMOTIDINE (PEPCID [FAMOTIDINE]) for Adverse event, at a dose of UNK dosage form. On 01-Mar-2021, PYREXIA (Fever of 101.6 degrees) had resolved. At the time of the report, THYROID DISORDER (Hyperthyroid symptoms), PAIN IN EXTREMITY (Intense pain in feet), PALPITATIONS (racing heartbeat), FEELING ABNORMAL (Intense brain fog) and LYMPHADENOPATHY (lymph nodes are swollen and inflamed) had not resolved and ABDOMINAL PAIN (Intense pain in abdomen), ANXIETY (Anxious), DYSMENORRHOEA (felt like she was having a period) and NAUSEA (nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Feb-2021, Blood thyroid stimulating hormone: elevated (High) Elevated. On 27-Feb-2021, Body temperature: 101.6 (High) 101.6.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's additional treatment medication included unspecified anti-inflammatory medication as per her physician's advise, but that did not help with her pain. The patient's second dose was scheduled for 27-Mar-2021.
Age: 38.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling abnormal, Lymphadenopathy, Nausea, Pain in extremity, Palpitations
Clinical narrative: Hyperthyroid symptoms; Intense pain in feet; racing heartbeat; Intense pain in abdomen; Intense brain fog; Anxious; felt like she was having a period; lymph nodes are swollen and inflamed; Fever of 101.6 degrees; nausea; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of THYROID DISORDER (Hyperthyroid symptoms), PAIN IN EXTREMITY (Intense pain in feet), PALPITATIONS (racing heartbeat), ABDOMINAL PAIN (Intense pain in abdomen) and FEELING ABNORMAL (Intense brain fog) in a 38-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 27-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 27-Feb-2021, the patient experienced THYROID DISORDER (Hyperthyroid symptoms), PAIN IN EXTREMITY (Intense pain in feet), PALPITATIONS (racing heartbeat), ABDOMINAL PAIN (Intense pain in abdomen), FEELING ABNORMAL (Intense brain fog), ANXIETY (Anxious), DYSMENORRHOEA (felt like she was having a period), LYMPHADENOPATHY (lymph nodes are swollen and inflamed), PYREXIA (Fever of 101.6 degrees) and NAUSEA (nausea). The patient was treated with CETIRIZINE HYDROCHLORIDE (ZYRTEC [CETIRIZINE HYDROCHLORIDE]) for Adverse event, at a dose of UNK dosage form and FAMOTIDINE (PEPCID [FAMOTIDINE]) for Adverse event, at a dose of UNK dosage form. On 01-Mar-2021, PYREXIA (Fever of 101.6 degrees) had resolved. At the time of the report, THYROID DISORDER (Hyperthyroid symptoms), PAIN IN EXTREMITY (Intense pain in feet), PALPITATIONS (racing heartbeat), FEELING ABNORMAL (Intense brain fog) and LYMPHADENOPATHY (lymph nodes are swollen and inflamed) had not resolved and ABDOMINAL PAIN (Intense pain in abdomen), ANXIETY (Anxious), DYSMENORRHOEA (felt like she was having a period) and NAUSEA (nausea) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 27-Feb-2021, Blood thyroid stimulating hormone: elevated (High) Elevated. On 27-Feb-2021, Body temperature: 101.6 (High) 101.6.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       The patient's additional treatment medication included unspecified anti-inflammatory medication as per her physician's advise, but that did not help with her pain. The patient's second dose was scheduled for 27-Mar-2021.